Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
80,761
-0.04%
|
$24,389,822
$302.75 P/Share
|
|
Apr 18
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.07%
|
$11,324
$298.82 P/Share
|
|
Apr 18
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.05%
|
$9,834
$298.82 P/Share
|
|
Apr 18
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+2.59%
|
$9,536
$298.82 P/Share
|
|
Apr 18
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.31%
|
$12,516
$298.82 P/Share
|
|
Apr 18
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+3.82%
|
$9,834
$298.82 P/Share
|
|
Apr 08
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
139,045
-0.03%
|
$43,103,950
$310.88 P/Share
|
|
Apr 07
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
70,955
-0.02%
|
$21,996,050
$310.32 P/Share
|
|
Apr 06
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
51,851
-0.0%
|
$15,607,151
$301.11 P/Share
|
|
Apr 05
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
113,756
-0.04%
|
$33,444,264
$294.4 P/Share
|
|
Apr 04
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
39,393
-0.04%
|
$11,542,149
$293.15 P/Share
|
|
Apr 01
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
165,376
-0.08%
|
$48,289,792
$292.7 P/Share
|
|
Mar 30
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
2,500
-0.0%
|
$730,000
$292.03 P/Share
|
|
Mar 29
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
4,341
-0.0%
|
$1,267,572
$292.68 P/Share
|
|
Mar 28
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,538
-0.01%
|
$2,201,096
$292.15 P/Share
|
|
Mar 21
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
35,245
-0.02%
|
$10,291,540
$292.74 P/Share
|
|
Mar 21
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.05%
|
$9,826
$289.64 P/Share
|
|
Mar 21
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+4.09%
|
$9,826
$289.64 P/Share
|
|
Mar 21
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.08%
|
$11,271
$289.64 P/Share
|
|
Mar 21
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
43
+0.31%
|
$12,427
$289.64 P/Share
|
|
Mar 21
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+2.74%
|
$9,537
$289.64 P/Share
|
|
Mar 18
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.07%
|
$60,480,000
$288.4 P/Share
|
|
Mar 17
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.07%
|
$62,260,000
$283.95 P/Share
|
|
Mar 17
2022
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
SELL
Open market or private sale
|
Direct |
673
-2.1%
|
$186,421
$277.2 P/Share
|
|
Mar 15
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,075
-0.03%
|
$60,080,475
$273.77 P/Share
|
|
Mar 14
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
173,085
-0.08%
|
$46,559,865
$269.73 P/Share
|
|
Mar 11
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
21,840
-0.02%
|
$5,874,960
$269.05 P/Share
|
|
Mar 10
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
184,982
-0.09%
|
$49,205,212
$266.79 P/Share
|
|
Mar 09
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,018
-0.01%
|
$5,324,788
$266.94 P/Share
|
|
Mar 04
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.05%
|
$55,020,000
$262.14 P/Share
|
|
Mar 01
2022
|
Marschall S Runge Director |
BUY
Open market or private purchase
|
Direct |
202
+1.29%
|
$49,692
$246.78 P/Share
|
|
Mar 01
2022
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
SELL
Open market or private sale
|
Direct |
675
-2.06%
|
$166,725
$247.56 P/Share
|
|
Mar 01
2022
|
Anat Hakim EVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,500
-28.31%
|
$871,500
$249.95 P/Share
|
|
Mar 01
2022
|
Anat Hakim EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,929
+39.07%
|
-
|
|
Feb 25
2022
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,660
-18.58%
|
$403,380
$243.84 P/Share
|
|
Feb 22
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.06%
|
$9,799
$239.13 P/Share
|
|
Feb 22
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
53
+0.39%
|
$12,667
$239.13 P/Share
|
|
Feb 22
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+3.41%
|
$9,560
$239.13 P/Share
|
|
Feb 22
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+5.11%
|
$9,799
$239.13 P/Share
|
|
Feb 22
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.09%
|
$11,233
$239.13 P/Share
|
|
Feb 16
2022
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,186
-21.53%
|
$531,198
$243.84 P/Share
|
|
Feb 16
2022
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Exercise of conversion of derivative security
|
Direct |
5,461
+34.98%
|
-
|
|
Feb 16
2022
|
Ilya Yuffa EVP & President, LLY Int'l |
SELL
Open market or private sale
|
Direct |
1,000
-7.92%
|
$242,000
$242.58 P/Share
|
|
Feb 15
2022
|
Ilya Yuffa EVP & President, LLY Int'l |
SELL
Open market or private sale
|
Direct |
1,000
-7.34%
|
$237,000
$237.45 P/Share
|
|
Feb 09
2022
|
Anat Ashkenazi EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,752
+15.47%
|
$1,397,736
$243.27 P/Share
|
|
Feb 09
2022
|
Stephen F Fry SVP, HR & Diversity |
BUY
Grant, award, or other acquisition
|
Direct |
12,339
+7.48%
|
$2,998,377
$243.27 P/Share
|
|
Feb 09
2022
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,435
+20.87%
|
$1,320,705
$243.27 P/Share
|
|
Feb 09
2022
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
BUY
Grant, award, or other acquisition
|
Direct |
2,036
+5.86%
|
$494,748
$243.27 P/Share
|
|
Feb 09
2022
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
2,612
+8.67%
|
$634,716
$243.27 P/Share
|
|
Feb 09
2022
|
Johna Norton EVP, Global Quality |
BUY
Grant, award, or other acquisition
|
Direct |
3,294
+9.82%
|
$800,442
$243.27 P/Share
|